Week Ending February 14, 2022
Survey Explores Mental Health of Patients With NSCLC During COVID-19
“Patients with non–small cell lung cancer (NSCLC) reported superior mental health well-being during the COVID-19 pandemic compared with a control population that did not have cancer.”
What Are Lung Cancer Clinical Trials?
“Lung cancer clinical trials are research studies that look for new and better ways to treat, detect, or improve quality of life with lung cancer at all stages of the disease.”
Can Lung Cancer Be Detected Through Blood Tests?
“Lung cancer is the most common cause of cancer deaths for people of any sex in the United States, causing more deaths than breast cancer, colon cancer, and prostate cancer combined. Unfortunately, lung cancer is often diagnosed in the later stages of the disease when treatment is less effective.”
CMS Broadens Coverage of Lung Cancer Screening
“CMS announced Thursday it will expand coverage for lung cancer screening completed via low dose computed technology (LDCT). The national coverage determination (NCD) aims to improve early detection of non-small cell lung cancer (NSCLC), which accounts for around 85% of all lung cancer cases.”
Specific Cancer Driving Protein Plays Important Role in Lung Cancer Development, Moffitt Researchers Say
“Lung cancer is the second most common cancer in the U.S. and the No. 1 cause of cancer related death. Despite considerable progress in treatment options, most lung cancer patients have extremely poor outcomes with an average five-year survival rate of 21.7%. To help identify new drug targets for this patient population, Moffitt Cancer Center researchers are working to improve their understanding of the molecular mechanisms behind lung cancer.”
Outreach boosts uptake of lung cancer screening in rural areas
“Compliance with low-dose CT (LDCT) lung cancer screening tends to be lower in rural communities, but outreach and patient navigation efforts can boost uptake, according to a study published February 7 in the Journal of the American College of Radiology.”
Patient Success Story: Beating Stage IV Lung Cancer
“AJ Patel had six months to live. Eight years later, he tells us how biomarker testing changed everything.”